We build long-lasting partnerships with the private sector
We remain open at all times to ideas, discussions, and collaborations to open the pipeline for the development of new antimicrobials. Basel houses many pharmaceutical headquarters and is therefore a prime location for making progress against AMR.
We have established strong collaborations up to this point, and plan to build more of these relationships and establish a strong foundation for drug development using our research. We invite and encourage pharmaceutical companies to talk to us about potential collaborative work.